The protected code blue is designed to keep your staff safe when managing a patient with COVID-19 who has a sudden cardiac arrest. You will continue to do high quality CPR, defibrillation (if indicated), give code medications, and BVM with ...
Background: Peripheral intravenous (PIV) access is one of the most commonly performed invasive procedures in unwell patients. Although, most patients can have PIVs placed by palpation, there is a subset of patients with difficult vascular access that will require ultrasound-guided ...
I have been thinking a lot about patients with COVID-19 and the pulmonary pattern that they develop. This disease process has been categorized like ARDS, but the reality is it is not like “typical” ARDS. Lung compliance is often normal ...
The American Heart Association (AHA) released a focused update in 2019, for advanced cardiovascular life support (ACLS) guidelines, to addend those published in 2017 and 2018 for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care. These recommendations were based on evidence ...
Background Information: Refractory ventricular fibrillation (RVF) is a complication of cardiac arrest defined as ventricular fibrillation (VF) that does not respond to three or more standard defibrillation attempts.1,2 Patients with RVF during their cardiac arrest have a mortality of up ...
Take-Home Points Before starting a neonatal resuscitation, take some deep breaths to calm yourself Call in your friends – get a second team to manage the mother, call OB, call the NICU – all hands on deck Anticipate the equipment ...
Background: The publication of the MR CLEAN trial in January 2015 changed the face of ischemic stroke care. This was the first study demonstrating a benefit to endovascular treatment of a specific subset of ischemic stroke patients: those with a ...
Background: The Surviving Sepsis Campaign published their recommendations for the management of patients with COVID-19 on March 20th, 2020 (though as of the date of this blog post, the document has not been peer reviewed). 36 experts from 12 countries ...
Background: Since the introduction of SARS-CoV-2 to the world in December 2019, there have been no medications approved or proven effective for the treatment of this pandemic. Lopinavir is an HIV protease inhibitor that is combined with Ritonavir to increase ...
On Feb 21st, a patient by the name of Aldo, a 72-year-old male, came to our ED with fever and progressive dyspnea. In addition, his chest x-ray showed an interstitial pattern. It was on this day that COVID19 had arrived ...
1 email per week. No spam.
Sponsored
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.
